Table 2 Mean (SD) values of Multiple Sclerosis Self-Efficacy Scale (MSSES) and Impact on Participation and Autonomy (IPA) scores at 1, 3 and 6 months after SCDP in the total group and in the Relapsing Remitting (RR) and Progressive (P) subgroups
Baseline | 1 month | 3 months | 6 months | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | RR | P | Total | RR | P | Total | RR | P | Total | RR | P | |
MSSES-Function | 66.45 (21.52) | 81.80 (12.15) | 53.59 (19.62) | 66.28 (21.29) | 81.70 (12.52) | 54.09 (19.31) | 64.47 (22.41) | 74.75 (19.33) | 54.23 (20.28) | 66.10 (21.93) | 81.30 (12.00) | 50.94 (18.07) |
MSSES-Control | 47.79 (19.06) | 57.01 (19.67) | 41.63 (15.29) | 49.33 (17.42) | 58.04 (15.01) | 43.84 (16.24) | 49.64 (19.76) | 53.52 (18.28) | 45.50 (20.77) | 55.05 (18.91) | 64.26 (13.66) | 46.18 (19.44) |
IPA-Limitations | 2.70 (0.57) | 2.43 (0.57) | 2.89 (0.50) | 2.59 (0.63) | 2.34 (0.53) | 2.76 (0.65) | 2.57 (0.62) | 2.26 (0.51) | 2.85 (0.56) | 2.58 (0.67) | 2.30 (0.55) | 2.88 (0.64) |
IPA-Problems | 2.09 (0.36) | 1.95 (0.36) | 2.17 (0.32) | 1.97 (0.46) | 1.73 (0.39) | 2.11 (0.43) | 1.93 (0.52) | 1.74 (0.48) | 2.07 (0.54) | 2.02 (0.51) | 1.86 (0.52) | 2.14 (0.48) |